Company Filing History:
1 out of 17 
1 out of 1,835 
1 out of 99 
Years Active: 1998-2018
Title: The Innovations of Mauro Piacentini
Introduction
Mauro Piacentini is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of human immunodeficiency virus type 1 (HIV-1) infections. With a total of two patents to his name, Piacentini's work reflects his dedication to advancing medical research and treatment options.
Latest Patents
Mauro Piacentini's latest patents include innovative methods and pharmaceutical compositions for treating HIV-1 infections. The first patent provides methods for treating HIV-1 infection in a subject in need thereof, which involves administering a therapeutically effective amount of an inhibitor of SGT1 activity or expression. The second patent focuses on a method for quantitatively measuring apoptosis, encompassing techniques for detecting and quantifying .epsilon.(.gamma.-glutamyl)lysine isodipeptide by catalytically releasing lysine and measuring free lysine.
Career Highlights
Throughout his career, Mauro Piacentini has worked with various organizations, including LXR Biotechnology, Inc. and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Mauro Piacentini has collaborated with esteemed colleagues such as Laszlo Fesus and Guido Kroemer. These partnerships have further enriched his research and innovation efforts.
Conclusion
Mauro Piacentini's contributions to the field of pharmaceutical sciences, particularly in HIV-1 treatment, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical research and improving patient outcomes.